Scientists and members of the public exploring the controversial area of U.S. human embryo and embryoid research will find a complex and sometimes bewildering assortment of federal and state laws. The authors recommend additional guidance, but note slow progress in the development of embryo research policy.
As the electricity sector transitions to renewable energy with distributed generation, investment in and regulation of energy transmission require careful consideration. This IAEE article analyzes the relevant issues.
Juan Rosellón, Mohammad Hesamzadeh, Darryl Biggar, Hossein HesamzadehAugust 25, 2021
Hospital at Home programs offer an alternative care model for acutely ill patients to receive intensive at-home treatment. With better policy and operations, can this model work at scale in the United States beyond the pandemic?
Anaeze C. Offodile II, Celynne Balatbat, Kushal T. Kadakia, Victor DzauAugust 23, 2021
To understand the variations and impact of national policies, the authors reviewed and analyzed IVF, hESC and human embryo research laws or national guidelines currently in place in the top R&D-investing nations. Regenerative Medicine, Aug. 17, 2020.
Kirstin R.W. Matthews, Daniel MoralíAugust 17, 2020
The global financial cost of Covid-19 could top $15 trillion. But governments could prevent future pandemics by investing as little as $22 billion a year in programs to curb wildlife trafficking and stem the destruction of tropical forests, according to an international team of scientists including Baker Institute Faculty Scholar Ted Loch-Temzelides.
Ted Loch-Temzelides, Andrew Dobson, Stuart Pimm, Lee Hannah, Les Kaufman, Jorge Ahumada, Amy Ando, Aaron Bernstein, Jonah Busch, Peter Daszak, Jens Engelmann, Margaret Kinnaird, Binbin Li, Thomas Lovejoy, Katarzyna Nowak, Patrick Roehrdanz, Mariana ValeJuly 24, 2020